Cross‑link between ferroptosis and nasopharyngeal carcinoma: New approach to radiotherapy sensitization (Review)
- Authors:
- Hai-Long Li
- Nian-Hua Deng
- Jia-Xin Xiao
- Xiu-Sheng He
-
Affiliations: Key Laboratory of Cancer Cellular and Molecular Pathology in Hunan Province, Cancer Research Institute of Medical College, University of South China, Hengyang, Hunan 421001, P.R. China, Key Lab for Arteriosclerology of Hunan Province, International Joint Laboratory for Arteriosclerotic Disease Research of Hunan Province, Institute of Cardiovascular Disease, University of South China, Hengyang, Hunan 421001, P.R. China - Published online on: September 9, 2021 https://doi.org/10.3892/ol.2021.13031
- Article Number: 770
-
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
|
Chen YP, Chan ATC, Le QT, Blanchard P, Sun Y and Ma J: Nasopharyngeal carcinoma. Lancet. 394:64–80. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Long M, Fu Z, Li P and Nie Z: Cigarette smoking and the risk of nasopharyngeal carcinoma: A meta-analysis of epidemiological studies. BMJ Open. 7:e0165822017. View Article : Google Scholar : PubMed/NCBI | |
|
Liu YP, Lv X, Zou X, Hua YJ, You R, Yang Q, Xia L, Guo SY, Hu W, Zhang MX, et al: Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma. Cancer Commun (Lond). 39:752019. View Article : Google Scholar : PubMed/NCBI | |
|
Jaffray DA: Image-guided radiotherapy: From current concept to future perspectives. Nat Rev Clin Oncol. 9:688–699. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Liu G, Zeng X, Wu B, Zhao J and Pan Y: RNA-Seq analysis of peripheral blood mononuclear cells reveals unique transcriptional signatures associated with radiotherapy response of nasopharyngeal carcinoma and prognosis of head and neck cancer. Cancer Biol Ther. 21:139–146. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Baidoo KE, Yong K and Brechbiel MW: Molecular pathways: Targeted α-particle radiation therapy. Clin Cancer Res. 19:530–537. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Srinivas US, Tan BWQ, Vellayappan BA and Jeyasekharan AD: ROS and the DNA damage response in cancer. Redox Biol. 25:1010842019. View Article : Google Scholar : PubMed/NCBI | |
|
Lee AWM, Ng WT, Chan JYW, Corry J, Mäkitie A, Mendenhall WM, Rinaldo A, Rodrigo JP, Saba NF, Strojan P, et al: Management of locally recurrent nasopharyngeal carcinoma. Cancer Treat Rev. 79:1018902019. View Article : Google Scholar : PubMed/NCBI | |
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al: Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Xu T, Ding W, Ji X, Ao X, Liu Y, Yu W and Wang J: Molecular mechanisms of ferroptosis and its role in cancer therapy. J Cell Mol Med. 23:4900–4912. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch A, Eggenhofer E, et al: Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 16:1180–1191. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Raven EP, Lu PH, Tishler TA, Heydari P and Bartzokis G: Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging. J Alzheimers Dis. 37:127–136. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Huang S, Cao B, Zhang J, Feng Y, Wang L, Chen X, Su H, Liao S, Liu J, Yan J and Liang B: Induction of ferroptosis in human nasopharyngeal cancer cells by cucurbitacin B: molecular mechanism and therapeutic potential. Cell Death Dis. 12:2372021. View Article : Google Scholar : PubMed/NCBI | |
|
Li Z, Chen L, Chen C, Zhou Y, Hu D, Yang J, Chen Y, Zhuo W, Mao M, Zhang X, et al: Targeting ferroptosis in breast cancer. Biomark Res. 8:582020. View Article : Google Scholar : PubMed/NCBI | |
|
Xie Y, Hou W, Song X, Yu Y, Huang J, Sun X, Kang R and Tang D: Ferroptosis: Process and function. Cell Death Differ. 23:369–379. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Kazan HH, Urfali-Mamatoglu C and Gunduz U: Iron metabolism and drug resistance in cancer. Biometals. 30:629–641. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
He YJ, Liu XY, Xing L, Wan X, Chang X and Jiang HL: Fenton reaction-independent ferroptosis therapy via glutathione and iron redox couple sequentially triggered lipid peroxide generator. Biomaterials. 241:1199112020. View Article : Google Scholar : PubMed/NCBI | |
|
Torti SV and Torti FM: Iron and cancer: More ore to be mined. Nat Rev Cancer. 13:342–355. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Liang C, Zhang X, Yang M and Dong X: Recent progress in ferroptosis inducers for cancer therapy. Adv Mater. 31:e19041972019. View Article : Google Scholar : PubMed/NCBI | |
|
Lin LS, Song J, Song L, Ke K, Liu Y, Zhou Z, Shen Z, Li J, Yang Z, Tang W and Niu G: Simultaneous fenton-like ion delivery and glutathione depletion by MnO2-based nanoagent to enhance chemodynamic therapy. Angew Chem Int Ed Engl. 57:4902–4906. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Lin D, Yu Q, Li Z, Lenahan C, Dong Y, Wei Q and Shao A: A promising future of ferroptosis in tumor therapy. Front Cell Dev Biol. 9:6291502021. View Article : Google Scholar : PubMed/NCBI | |
|
Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Stockwell BR, Jiang X and Gu W: Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol. 30:478–490. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sato H, Tamba M, Ishii T and Bannai S: Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem. 274:11455–11458. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Lo M, Ling V, Wang YZ and Gout PW: The xc-cystine/glutamate antiporter: A mediator of pancreatic cancer growth with a role in drug resistance. Br J Cancer. 99:464–472. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Gao M, Yi J, Zhu J, Minikes AM, Monian P, Thompson CB and Jiang X: Role of mitochondria in ferroptosis. Mol Cell. 73:354–363.e3. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Tang D, Chen X, Kang R and Kroemer G: Ferroptosis: Molecular mechanisms and health implications. Cell Res. 31:107–125. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM, Boniface J, et al: RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature. 447:864–868. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Yang WH, Huang Z, Wu J, Ding CC, Murphy SK and Chi JT: A TAZ-ANGPTL4-NOX2 axis regulates ferroptotic cell death and chemoresistance in epithelial ovarian cancer. Mol Cancer Res. 18:79–90. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lang X, Green MD, Wang W, Yu J, Choi JE, Jiang L, Liao P, Zhou J, Zhang Q, Dow A, et al: Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11. Cancer Discov. 9:1673–1685. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Lei G, Mao C, Yan Y, Zhuang L and Gan B: Ferroptosis, radiotherapy, and combination therapeutic strategies. Protein Cell. Apr 23–2021.(Epub ahead of print). View Article : Google Scholar | |
|
Ye LF, Chaudhary KR, Zandkarimi F, Harken AD, Kinslow CJ, Upadhyayula PS, Dovas A, Higgins DM, Tan H, Zhang Y, et al: Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers. ACS Chem Biol. 15:469–484. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lei G, Zhang Y, Koppula P, Liu X, Zhang J, Lin SH, Ajani JA, Xiao Q, Liao Z, Wang H and Gan B: The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res. 30:146–162. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Xie L, Song X, Yu J, Guo W, Wei L, Liu Y and Wang X: Solute carrier protein family may involve in radiation-induced radioresistance of non-small cell lung cancer. J Cancer Res Clin Oncol. 137:1739–1747. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
McDonald JT, Kim K, Norris AJ, Vlashi E, Phillips TM, Lagadec C, Della Donna L, Ratikan J, Szelag H, Hlatky L and McBride WH: Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res. 70:8886–8895. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Zong Y, Feng S, Cheng J, Yu C and Lu G: Up-regulated ATF4 expression increases cell sensitivity to apoptosis in response to radiation. Cell Physiol Biochem. 41:784–794. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Koppula P, Zhuang L and Gan B: Cystine transporter SLC7A11/xCT in cancer: Ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 12:599–620. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Maier P, Hartmann L, Wenz F and Herskind C: Cellular pathways in response to ionizing radiation and their targetability for tumor radiosensitization. Int J Mol Sci. 17:1022016. View Article : Google Scholar : PubMed/NCBI | |
|
Stracker TH, Roig I, Knobel PA and Marjanović M: The ATM signaling network in development and disease. Front Genet. 4:372013. View Article : Google Scholar : PubMed/NCBI | |
|
Sanli T, Steinberg GR, Singh G and Tsakiridis T: AMP-activated protein kinase (AMPK) beyond metabolism: Anovel genomic stress sensor participating in the DNA damage response pathway. Cancer Biol Ther. 15:156–169. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Degterev A and Yuan J: Expansion and evolution of cell death programmes. Nat Rev Mol Cell Biol. 9:378–390. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Gudkov AV and Komarova EA: The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer. 3:117–129. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Kirtonia A, Sethi G and Garg M: The multifaceted role of reactive oxygen species in tumorigenesis. Cell Mol Life Sci. 77:4459–4483. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Halliwell B and Cross CE: Oxygen-derived species: Their relation to human disease and environmental stress. Environ Health Perspect. 102 (Suppl 10):S5–S12. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Grivennikova VG and Vinogradov AD: Generation of superoxide by the mitochondrial Complex I. Biochim Biophys Acta. 1757:553–561. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Hentze MW, Muckenthaler MU, Galy B and Camaschella C: Two to tango: Regulation of mammalian iron metabolism. Cell. 142:24–38. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Gutteridge JM and Halliwell B: Iron toxicity and oxygen radicals. Baillieres Clin Haematol. 2:195–256. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Doll S and Conrad M: Iron and ferroptosis: A still ill-defined liaison. IUBMB Life. 69:423–434. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Andrews NC: Disorders of iron metabolism. N Engl J Med. 341:1986–1995. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Li B, Liao Z, Mo Y, Zhao W, Zhou X, Xiao X, Cui W, Feng G, Zhong S, Liang Y, et al: Inactivation of 3-hydroxybutyrate dehydrogenase type 2 promotes proliferation and metastasis of nasopharyngeal carcinoma by iron retention. Br J Cancer. 122:102–110. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Y, Wang Q, Li X, Chen Y and Xu G: Itraconazole attenuates the stemness of nasopharyngeal carcinoma cells via triggering ferroptosis. Environ Toxicol. 36:257–266. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Andrews NC: Forging a field: The golden age of iron biology. Blood. 112:219–230. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Ivanov SD, Semenov AL, Kovan'ko EG and Yamshanov VA: Effects of iron ions and iron chelation on the efficiency of experimental radiotherapy of animals with gliomas. Bull Exp Biol Med. 158:800–803. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ III, Kang R and Tang D: Autophagy promotes ferroptosis by degradation of ferritin. Autophagy. 12:1425–1428. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Park E and Chung SW: ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis. 10:8222019. View Article : Google Scholar : PubMed/NCBI | |
|
Hong X, Roh W, Sullivan RJ, Wong KHK, Wittner BS, Guo H, Dubash TD, Sade-Feldman M, Wesley B, Horwitz E, et al: The lipogenic regulator SREBP2 induces transferrin in circulating melanoma cells and suppresses ferroptosis. Cancer Discov. 11:678–695. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Feng H, Schorpp K, Jin J, Yozwiak CE, Hoffstrom BG, Decker AM, Rajbhandari P, Stokes ME, Bender HG, Csuka JM, et al: Transferrin receptor is a specific ferroptosis marker. Cell Rep. 30:3411–3423.e7. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yang WS and Stockwell BR: Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem Biol. 15:234–245. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Guagnozzi D, Severi C, Ialongo P, Viscido A, Patrizi F, Testino G, Vannella L, Labriola R, Strom R and Caprilli R: Ferritin as a simple indicator of iron deficiency in anemic IBD patients. Inflamm Bowel Dis. 12:150–151. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Ma BB, Leungm SF, Hui EP, Mo F, Kwan WH, Zee B, Yuen J and Chan AT: Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy. Cancer. 101:776–781. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Long X, Liang Z, Lei H, Li L, Qu S and Zhu X: Higher N stage and serum ferritin, but lower serum albumin levels are associated with distant metastasis and poor survival in patients with nasopharyngeal carcinoma following intensity-modulated radiotherapy. Oncotarget. 8:73177–73186. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang W, Fan S, Zou G, Shi L, Zeng Z, Ma J, Zhou Y, Li X, Zhang X, Li X, et al: Lactotransferrin could be a novel independent molecular prognosticator of nasopharyngeal carcinoma. Tumour Biol. 36:675–683. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Y, Zeng Z, Zhang W, Xiong W, Wu M, Tan Y, Yi W, Xiao L, Li X, Huang C, et al: Lactotransferrin: A candidate tumor suppressor-deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway. Int J Cancer. 123:2065–2072. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Feng X, Liu W, Jiang X, Shan W, Huang C, Yi H, Zhu B, Zhou W, Wang L, et al: Underlying mechanisms for LTF inactivation and its functional analysis in nasopharyngeal carcinoma cell lines. J Cell Biochem. 112:1832–1843. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Deng M, Zhang W, Tang H, Ye Q, Liao Q, Zhou Y, Wu M, Xiong W, Zheng Y, Guo X, et al: Lactotransferrin acts as a tumor suppressor in nasopharyngeal carcinoma by repressing AKT through multiple mechanisms. Oncogene. 32:4273–4283. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Song M, Bode AM, Dong Z and Lee MH: AKT as a therapeutic target for cancer. Cancer Res. 79:1019–1031. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Dodson M, Castro-Portuguez R and Zhang DD: NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol. 23:1011072019. View Article : Google Scholar : PubMed/NCBI | |
|
Qiang Z, Dong H, Xia Y, Chai D, Hu R and Jiang H: Nrf2 and STAT3 alleviates ferroptosis-mediated IIR-ALI by regulating SLC7A11. Oxid Med Cell Longev. 2020:51469822020. View Article : Google Scholar : PubMed/NCBI | |
|
Sun X, Ou Z, Chen R, Niu X, Chen D, Kang R and Tang D: Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology. 63:173–184. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Cloer EW, Goldfarb D, Schrank TP, Weissman BE and Major MB: NRF2 activation in cancer: From DNA to protein. Cancer Res. 79:889–898. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Huang W, Shi G, Yong Z, Li J, Qiu J, Cao Y, Zhao Y and Yuan L: Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p. Cell Death Dis. 11:5042020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou J, Ding J, Ma X, Zhang M, Huo Z, Yao Y, Li D and Wang Z: The NRF2/KEAP1 pathway modulates nasopharyngeal carcinoma cell radiosensitivity via ROS elimination. Onco Targets Ther. 13:9113–9122. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang G, Wang W, Yao C, Ren J, Zhang S and Han M: Salinomycin overcomes radioresistance in nasopharyngeal carcinoma cells by inhibiting Nrf2 level and promoting ROS generation. Biomed Pharmacother. 91:147–154. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Yun SM, Kim YS and Hur DY: LMP1 and 2A induce the expression of Nrf2 through Akt signaling pathway in Epstein-Barr virus-transformed B cells. Transl Oncol. 12:775–783. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Hsu JL, Chou JW, Chen TF, Hsu JT, Su FY, Lan JL, Wu PC, Hu CM, Lee EY and Lee WH: Glutathione peroxidase 8 negatively regulates caspase-4/11 to protect against colitis. EMBO Mol Med. 12:e93862020. View Article : Google Scholar : PubMed/NCBI | |
|
Koeberle SC, Gollowitzer A, Laoukili J, Kranenburg O, Werz O, Koeberle A and Kipp AP: Distinct and overlapping functions of glutathione peroxidases 1 and 2 in limiting NF-κB-driven inflammation through redox-active mechanisms. Redox Biol. 28:1013882020. View Article : Google Scholar : PubMed/NCBI | |
|
Maiorino M, Conrad M and Ursini F: GPx4, lipid peroxidation, and cell death: Discoveries, rediscoveries, and open issues. Antioxid Redox Signal. 29:61–74. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Nunes SC and Serpa J: Glutathione in ovarian cancer: A Double-edged sword. Int J Mol Sci. 19:18822018. View Article : Google Scholar : PubMed/NCBI | |
|
Meng DF, Guo LL, Peng LX, Zheng LS, Xie P, Mei Y, Li CZ, Peng XS, Lang YH, Liu ZJ, et al: Antioxidants suppress radiation-induced apoptosis via inhibiting MAPK pathway in nasopharyngeal carcinoma cells. Biochem Biophys Res Commun. 527:770–777. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Song X, Xie Y, Kang R, Hou W, Sun X, Epperly MW, Greenberger JS and Tang D: FANCD2 protects against bone marrow injury from ferroptosis. Biochem Biophys Res Commun. 480:443–449. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Bao Y, Feng H, Zhao F, Zhang L, Xu S, Zhang C, Zhao C and Qin G: FANCD2 knockdown with shRNA interference enhances the ionizing radiation sensitivity of nasopharyngeal carcinoma CNE-2 cells. Neoplasma. 68:40–52. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Xu S, Zhao F, Liang Z, Feng H, Bao Y, Xu W, Zhao C and Qin G: Expression of FANCD2 is associated with prognosis in patients with nasopharyngeal carcinoma. Int J Clin Exp Pathol. 12:3465–3473. 2019.PubMed/NCBI | |
|
Suttner DM and Dennery PA: Reversal of HO-1 related cytoprotection with increased expression is due to reactive iron. FASEB J. 13:1800–1809. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Adedoyin O, Boddu R, Traylor A, Lever JM, Bolisetty S, George JF and Agarwal A: Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells. Am J Physiol Renal Physiol. 314:F702–F714. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Shi L and Fang J: Implication of heme oxygenase-1 in the sensitivity of nasopharyngeal carcinomas to radiotherapy. J Exp Clin Cancer Res. 27:132008. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R and Gu W: Ferroptosis as a p53-mediated activity during tumour suppression. Nature. 520:57–62. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wang SJ, Li D, Ou Y, Jiang L, Chen Y, Zhao Y and Gu W: Acetylation is crucial for p53-mediated ferroptosis and tumor suppression. Cell Rep. 17:366–373. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J, Zhong M, Yuan H, Zhang L, Billiar TR, et al: The tumor suppressor p53 limits Ferroptosis by blocking DPP4 activity. Cell Rep. 20:1692–1704. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Z, Mao JW, Liu GY, Wang FG, Ju ZS, Zhou D and Wang RY: MicroRNA-372 enhances radiosensitivity while inhibiting cell invasion and metastasis in nasopharyngeal carcinoma through activating the PBK-dependent p53 signaling pathway. Cancer Med. 8:712–728. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ma WS, Ma JG and Xing LN: Efficacy and safety of recombinant human adenovirus p53 combined with chemoradiotherapy in the treatment of recurrent nasopharyngeal carcinoma. Anticancer Drugs. 28:230–236. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Song X, Zhu S, Chen P, Hou W, Wen Q, Liu J, Xie Y, Liu J, Klionsky DJ, Kroemer G, et al: AMPK-mediated BECN1 phosphorylation promotes ferroptosis by directly blocking System Xc− activity. Curr Biol. 28:2388–2399.e5. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Kang R, Zhu S, Zeh HJ, Klionsky DJ and Tang D: BECN1 is a new driver of ferroptosis. Autophagy. 14:2173–2175. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wan XB, Fan XJ, Chen MY, Xiang J, Huang PY, Guo L, Wu XY, Xu J, Long ZJ, Zhao Y, et al: Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy. 6:395–404. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Chen W, Lian J, Zhang H, Yu B, Zhang M, Wei F, Wu J, Jiang J, Jia Y, et al: The lncRNA PVT1 regulates nasopharyngeal carcinoma cell proliferation via activating the KAT2A acetyltransferase and stabilizing HIF-1α. Cell Death Differ. 27:695–710. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Majidinia M, Karimian A, Alemi F, Yousefi B and Safa A: Targeting miRNAs by polyphenols: Novel therapeutic strategy for aging. Biochem Pharmacol. 173:1136882020. View Article : Google Scholar : PubMed/NCBI | |
|
Ding C, Ding X, Zheng J, Wang B, Li Y, Xiang H, Dou M, Qiao Y, Tian P and Xue W: miR-182-5p and miR-378a-3p regulate ferroptosis in I/R-induced renal injury. Cell Death Dis. 11:9292020. View Article : Google Scholar : PubMed/NCBI | |
|
Deng SH, Wu DM, Li L, Liu T, Zhang T, Li J, Yu Y, He M, Zhao YY, Han R and Xu Y: miR-324-3p reverses cisplatin resistance by inducing GPX4-mediated ferroptosis in lung adenocarcinoma cell line A549. Biochem Biophys Res Commun. 549:54–60. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Xiao FJ, Zhang D, Wu Y, Jia QH, Zhang L, Li YX, Yang YF, Wang H, Wu CT and Wang LS: miRNA-17-92 protects endothelial cells from erastin-induced ferroptosis through targeting the A20-ACSL4 axis. Biochem Biophys Res Commun. 515:448–454. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Ma LL, Liang L, Zhou D and Wang SW: Tumor suppressor miR-424-5p abrogates ferroptosis in ovarian cancer through targeting ACSL4. Neoplasma. 68:165–173. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Tomita K, Fukumoto M, Itoh K, Kuwahara Y, Igarashi K, Nagasawa T, Suzuki M, Kurimasa A and Sato T: MiR-7-5p is a key factor that controls radioresistance via intracellular Fe2+ content in clinically relevant radioresistant cells. Biochem Biophys Res Commun. 518:712–718. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang K, Wu L, Zhang P, Luo M, Du J, Gao T, O'Connell D, Wang G, Wang H and Yang Y: miR-9 regulates ferroptosis by targeting glutamic-oxaloacetic transaminase GOT1 in melanoma. Mol Carcinog. 57:1566–1576. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Luo M, Wu L, Zhang K, Wang H, Zhang T, Gutierrez L, O'Connell D, Zhang P, Li Y, Gao T, et al: miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma. Cell Death Differ. 25:1457–1472. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Qi YF, Yang Y, Zhang Y, Liu S, Luo B and Liu W: Down regulation of lactotransferrin enhanced radio-sensitivity of nasopharyngeal carcinoma. Comput Biol Chem. 90:1074262021. View Article : Google Scholar : PubMed/NCBI | |
|
He W, Jin H, Liu Q and Sun Q: miR-182-5p contributes to radioresistance in nasopharyngeal carcinoma by regulating BNIP3 expression. Mol Med Rep. 23:1302021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Zheng L, Lin S, Liu Y, Wang Y and Gao F: MiR-124 enhances cell radiosensitivity by targeting PDCD6 in nasopharyngeal carcinoma. Int J Clin Exp Pathol. 10:11461–11470. 2017.PubMed/NCBI | |
|
Tian Y, Tian Y, Tu Y, Zhang G, Zeng X, Lin J, Ai M, Mao Z, Zheng R and Yuan Y: microRNA-124 inhibits stem-like properties and enhances radiosensitivity in nasopharyngeal carcinoma cells via direct repression of expression of JAMA. J Cell Mol Med. 24:9533–9544. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Chen L, Zhou H and Guan Z: CircRNA_000543 knockdown sensitizes nasopharyngeal carcinoma to irradiation by targeting miR-9/platelet-derived growth factor receptor B axis. Biochem Biophys Res Commun. 512:786–792. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Hu JL, He GY, Lan XL, Zeng ZC, Guan J, Ding Y, Qian XL, Liao WT, Ding YQ and Liang L: Inhibition of ATG12-mediated autophagy by miR-214 enhances radiosensitivity in colorectal cancer. Oncogenesis. 7:162018. View Article : Google Scholar : PubMed/NCBI | |
|
Han JB, Huang ML, Li F, Yang R, Chen SM and Tao ZZ: MiR-214 mediates cell proliferation and apoptosis of nasopharyngeal carcinoma through targeting both WWOX and PTEN. Cancer Biother Radiopharm. 35:615–625. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang ZC, Li YY, Wang HY, Fu S, Wang XP, Zeng MS, Zeng YX and Shao JY: Knockdown of miR-214 promotes apoptosis and inhibits cell proliferation in nasopharyngeal carcinoma. PLoS One. 9:e861492014. View Article : Google Scholar : PubMed/NCBI | |
|
He J, Tang Y and Tian Y: MicroRNA-214 promotes proliferation and inhibits apoptosis via targeting Bax in nasopharyngeal carcinoma cells. Mol Med Rep. 12:6286–6292. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Deng M, Ye Q, Qin Z, Zheng Y, He W, Tang H, Zhou Y, Xiong W, Zhou M, Li X, et al: miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma. Tumour Biol. 34:1793–1800. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Deng X, Ma L, Wu M, Zhang G, Jin C, Guo Y and Liu R: miR-124 radiosensitizes human glioma cells by targeting CDK4. J Neurooncol. 114:263–274. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Luo Y, Wang J, Wang F, Liu X, Lu J, Yu X, Ma X, Peng X and Li X: Foxq1 promotes metastasis of nasopharyngeal carcinoma by inducing vasculogenic mimicry via the EGFR signaling pathway. Cell Death Dis. 12:4112021. View Article : Google Scholar : PubMed/NCBI | |
|
Lu J, Xu F and Lu H: LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53. Life Sci. 260:1183052020. View Article : Google Scholar : PubMed/NCBI | |
|
Bao WD, Zhou XT, Zhou LT, Wang F, Yin X, Lu Y, Zhu LQ and Liu D: Targeting miR-124/Ferroportin signaling ameliorated neuronal cell death through inhibiting apoptosis and ferroptosis in aged intracerebral hemorrhage murine model. Aging Cell. 19:e132352020. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Chen F, Chen J, Chan S, He Y, Liu W and Zhang G: Disulfiram/Copper induces antitumor activity against both nasopharyngeal cancer cells and cancer-associated fibroblasts through ROS/MAPK and Ferroptosis pathways. Cancers (Basel). 12:1382020. View Article : Google Scholar : PubMed/NCBI | |
|
He X, Yao Q, Fan D, Duan L, You Y, Liang W, Zhou Z, Teng S, Liang Z, Hall DD, et al: Cephalosporin antibiotics specifically and selectively target nasopharyngeal carcinoma through HMOX1-induced ferroptosis. Life Sci. 277:1194572021. View Article : Google Scholar : PubMed/NCBI | |
|
Shibata Y, Yasui H, Higashikawa K, Miyamoto N and Kuge Y: Erastin, a ferroptosis-inducing agent, sensitized cancer cells to X-ray irradiation via glutathione starvation in vitro and in vivo. PLoS One. 14:e02259312019. View Article : Google Scholar : PubMed/NCBI | |
|
Li M, Wang X, Lu S, He C, Wang C, Wang L, Wang X, Ge P and Song D: Erastin triggers autophagic death of breast cancer cells by increasing intracellular iron levels. Oncol Lett. 20:572020.PubMed/NCBI | |
|
Tam SY, Wu VW and Law HK: Influence of autophagy on the efficacy of radiotherapy. Radiat Oncol. 12:572017. View Article : Google Scholar : PubMed/NCBI | |
|
Mou Y, Wang J, Wu J, He D, Zhang C, Duan C and Li B: Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 12:342019. View Article : Google Scholar : PubMed/NCBI | |
|
Friedmann Angeli JP, Krysko DV and Conrad M: Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat Rev Cancer. 19:405–414. 2019. View Article : Google Scholar : PubMed/NCBI |
